Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis

被引:23
作者
Angulo, Sandra
Llopis, Marta
Antolin, Maria
Gironella, Meritxell
Sans, Miquel
Malagelada, Juan Ramon
Pique, Josep Maria
Guarner, Francisco
Panes, Julian
机构
[1] Univ Barcelona, Dept Gastroenterol, Hosp Clin Barcelona, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Gen Valle Hebron, Digest Syst Res Unit, Barcelona 7, Spain
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2006年 / 291卷 / 06期
关键词
inflammatory bowel diseases; probiotics; cell adhesion molecules; endothelium;
D O I
10.1152/ajpgi.00446.2005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lactobacillus casei has been shown to attenuate the severity of experimental colitis. The objective of the present study was to determine whether the effects of L. casei on colitis are related to modulation of leukocyte recruitment into the inflamed intestine. Rats with a colonic segment excluded from fecal transit were surgically prepared. The segment was decontaminated with antibiotics and recolonized with normal flora isolated from the inflamed rat colon, associated or not to L. casei. Control and colitic [2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced] animals were studied. Leukocyte-endothelial cell interactions were characterized in the colonic microcirculation by intravital microscopy, and ICAM-1 and VCAM-1 expression was measured by the radiolabeled antibody technique. Compared with the noninflamed colonic segment, induction of colitis by TNBS provoked a marked increase in the number of leukocytes firmly adherent to the venular wall (0.5 +/- 0.1 vs. 2.1 +/- 0.6 leukocytes/100 mu m, P < 0.01). Colonization with L. casei significantly reduced the number of adherent leukocytes (1.3 +/- 0.4 leukocytes/100 mu m; P < 0.05) but did not affect the increased rolling interactions associated with the induction of colitis. Compared with the noncolitic group, induction of colitis was associated with a marked increase in ICAM-1 expression (117 +/- 4 vs. 180 +/- 3 ng antibody/g tissue) that was abrogated when the colitic segment was colonized by L. casei (117 +/- 3 ng antibody/g tissue, P < 0.05). However, L. casei administration did not modify VCAM-1 upregulation in colitic animals. L. casei attenuates leukocyte recruitment observed in experimental colitis induced by TNBS. This effect is possibly related to abrogation of ICAM-1 upregulation.
引用
收藏
页码:G1155 / G1162
页数:8
相关论文
共 42 条
[1]   REACTIVATION OF HAPTEN-INDUCED COLITIS AND ITS PREVENTION BY ANTIINFLAMMATORY DRUGS [J].
APPLEYARD, CB ;
WALLACE, JL .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (01) :G119-G125
[2]   Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria [J].
Borruel, N ;
Carol, M ;
Casellas, F ;
Antolín, M ;
de Lara, F ;
Espín, E ;
Naval, J ;
Guarner, F ;
Malagelada, JR .
GUT, 2002, 51 (05) :659-664
[3]  
Borruel N, 2003, AM J GASTROENTEROL, V98, P865, DOI 10.1111/j.1572-0241.2003.07384.x
[4]   A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates [J].
Canducci, F ;
Armuzzi, A ;
Cremonini, F ;
Cammarota, G ;
Bartolozzi, F ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) :1625-1629
[5]   A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease [J].
Colombel, JF ;
Lémann, M ;
Cassagnou, M ;
Bouhnik, Y ;
Duclos, B ;
Dupas, JL ;
Notteghem, B ;
Mary, JY .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) :674-678
[6]   DETERMINATION OF VOLUMETRIC FLOW IN CAPILLARY TUBES USING AN OPTICAL DOPPLER-VELOCIMETER [J].
DAVIS, MJ .
MICROVASCULAR RESEARCH, 1987, 34 (02) :223-230
[7]  
FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
[8]   Incrimination of anaerobic bacteria in the induction of experimental colitis [J].
GarciaLafuente, A ;
Antolin, M ;
Guarner, F ;
Crespo, E ;
Salas, A ;
Forcada, P ;
Laguarda, M ;
Gavalda, J ;
Baena, JA ;
Vilaseca, J ;
Malagelada, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 272 (01) :G10-G15
[9]   Natalizumab for active Crohn's disease. [J].
Ghosh, S ;
Goldin, E ;
Gordon, FH ;
Malchow, HA ;
Rask-Madsen, J ;
Rutgeerts, P ;
Vyhnalek, P ;
Zádorová, Z ;
Palmer, T ;
Donoghue, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :24-32
[10]   THE ASSESSMENT OF FECAL FLORA IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE BY A SIMPLIFIED BACTERIOLOGICAL TECHNIQUE [J].
GIAFFER, MH ;
HOLDSWORTH, CD ;
DUERDEN, BI .
JOURNAL OF MEDICAL MICROBIOLOGY, 1991, 35 (04) :238-243